Delivery Order SPE2DB22D1106-SPE2DB25FEQW8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,342.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on July 21, 2025, with completion targeted for July 22, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $5,943.99 to supply Trulicity 1.5 mg/0.5 mL pens on a firm fixed price basis. The order was competitively awarded without set-aside designation and is scheduled for completion by September 3, 2025. AmerisourceBergen will perform the work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,108.74 to supply Trulicity 1.5 mg/0.5 mL pens on a firm fixed price basis, with an ultimate completion date of September 3, 2025. This is a non-set-aside competitive award where the pharmaceutical distributor will fulfill the delivery order from its facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major healthcare solutions provider and pharmaceutical distributor serving as a...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $1,862.58 on August 11, 2025, for the supply of Trulicity 1.5 mg/0.5 mL pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 12, 2025, and performance executed from AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,292.25 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on July 28, 2025, with an ultimate completion date of July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a delivery order under the company's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be delivered to Conshohocken,...
- The Defense Logistics Agency awarded a $4,463.36 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens on July 24, 2025, with a completion date of July 25, 2025. This non-set-aside award was competitively awarded and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $4,239.60 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens on September 9, 2025, with completion expected by September 10, 2025. This is a firm fixed price, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a delivery order valued at $4,824.36 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL unit dose). This competitively awarded, non-set-aside contract reflects a firm fixed price arrangement with a completion date of September 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- The Defense Logistics Agency awarded a $19,238.49 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 4.5 mg/0.5 ml pens on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,194.93 to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 mL pens (0.5 mL dosage). The contract utilizes firm fixed-price pricing with no set-aside designation and is classified as a competitive award. Performance will be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 15, 2025. This delivery order represents a child...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEQW8Delivery Order
The Defense Logistics Agency (DLA) awarded a $26,276.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Trulicity 1.5 mg/0.5 ml pens. This is a non-set-aside competitive award with an ultimate completion date of June 2, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the company to distribute a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to supply diverse pharmaceutical products including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Trulicity, a diabetes medication, is representative of the company's ongoing role in fulfilling federal medical supply needs through the DLA's Medical Supply Chain, which supports various government healthcare systems including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $26.3k | 5/30/25 |